Koninklijke Philips N.V (1PHIA) Fair Value & Analysis
Healthcare · IT · Market cap €23.6B
Fair value as of: Jul 3, 2026
From 24 valuation models · updated 2 days ago
Share price +12.7% over the past month.
Price vs Fair Value (12 months)
12‑month range €19.26 – €26.25 · fair‑value band €8.04 – €12.26 · the €24.31 price screens above the €9.97 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Koninklijke Philips N.V (1PHIA) currently trades at €24.31, while our model-based Fair Value estimate is €9.97 — implying the stock looks roughly 59.0% overvalued today. We read business quality at 61/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Koninklijke Philips N.V generated revenue of €17.6B at a net margin of 5.5%. Revenue declined 4.7% year over year. It earns a return on equity of 8.4%. Net debt stands at €4.1B. Fundamentals as of Jul 3, 2026
Our scenario range runs from €8.04 (bear case) to €12.26 (bull case); at €24.31, the current price sits above that range. The share trades about 10% below its 52-week high and 26% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -22% fair-value upside — at -59%, 1PHIA screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Koninklijke Philips N.V reported revenue of €17.8B in FY2025 versus €17.8B in FY2022, a compound +0.0%/yr. Reported net income was €895M in FY2025.
Is 1PHIA fairly valued? → Check now
Recent news
- Is Koninklijke Philips (ENXTAM:PHIA) Above Fair Value After Recent AI Wins?
- 1 Unpopular Stock That Should Get More Attention and 2 Facing Headwinds
- Microsoft Takes Sisvel Wi-Fi Multimode Patent Pool Licence
- University Health in San Antonio selects Philips enterprise monitoring platform to transform patient monitoring and advance system-wide stan
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | 1,600 MXN | 82.40 MXN | -95% |
| Stryker Corporation S1YK34 | R$79.21 | R$43.74 | -45% |
| Medtronic plc MDT | $81.67 | $60.02 | -27% |
| Boston Scientific Corporation B1SX34 | R$248.75 | R$221.81 | -11% |
| Edwards Lifesciences Corporation EW | $85.98 | $41.02 | -52% |
| Siemens Healthineers AG SEMHF | $39.95 | $44.36 | +11% |
| GE HealthCare Technologies Inc GEHC | $61.99 | $48.34 | -22% |
| DexCom, Inc DXCM | $69.07 | $65.56 | -5% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥143.50 | ¥111.50 | -22% |
| STERIS plc STE | $200.40 | $176.96 | -12% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Koninklijke Philips N.V (1PHIA) undervalued?
What is the fair value of 1PHIA?
What is the quality score of 1PHIA?
What is the revenue of Koninklijke Philips N.V (1PHIA)?
What is the net profit margin of 1PHIA?
Does Koninklijke Philips N.V pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.